Waltz Health and Fresenius Kabi offer three biosimilars to employers and payers
AI Summary- Waltz Health and Fresenius Kabi teamed up to provide direct biosimilar access.
- Three competitively priced biosimilars target immunology and inflammatory diseases.
- Employers, payers and pharmacy benefit managers are the intended access points.